BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12569874)

  • 1. U.S. blocks trade agreement on generic drug access in poor countries.
    James JS
    AIDS Treat News; 2002 Dec; (386):4-6. PubMed ID: 12569874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
    Sawyer E
    AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 5. Global patent police block cost-reduction efforts.
    Kasper T
    GMHC Treat Issues; 1999 Mar; 13(3):1-2. PubMed ID: 11366201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent rules must not hinder access to cheap drugs in poor countries, experts say.
    Zarocostas J
    BMJ; 2011 Feb; 342():d1219. PubMed ID: 21343204
    [No Abstract]   [Full Text] [Related]  

  • 7. Patents and access to drugs in developing countries: an ethical analysis.
    Sterckx S
    Dev World Bioeth; 2004 May; 4(1):58-75. PubMed ID: 15086374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WTO accepts rules limiting medicine exports to poor countries.
    James JS
    AIDS Treat News; 2003 Sep; (394):2-6. PubMed ID: 14669728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compulsory licensing for bridging the gap - treatment access in developing countries: interview with James Love, Consumer Project on Technology. Interview by John S. James.
    Love J
    AIDS Treat News; 1999 Mar; (No 314):1-7. PubMed ID: 11366241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to generic antiretrovirals: inequality, intellectual property law, and international trade agreements.
    Castro A; Westerhaus M
    Cad Saude Publica; 2007; 23 Suppl 1():S85-96. PubMed ID: 17308722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The WTO's balancing act.
    Novak K
    J Clin Invest; 2003 Nov; 112(9):1269-73. PubMed ID: 14597749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAFTA will harm HIV care, according to critics. Final agreement helps drug companies, they say.
    AIDS Alert; 2004 Feb; 19(2):17-8. PubMed ID: 15011625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond.
    Rosina MS; Shaver L
    J Law Med Ethics; 2012; 40(2):197-205. PubMed ID: 22789040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US trade rules seek to balance health and patent protection.
    Wadman M; Cherry M
    Nature; 1999 Dec; 402(6762):567-8. PubMed ID: 10604448
    [No Abstract]   [Full Text] [Related]  

  • 15. University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.
    Crager SE; Guillen E; Price M
    Am J Law Med; 2009; 35(2-3):253-79. PubMed ID: 19697749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U.S. near accord with WTO over generic drug access.
    AIDS Policy Law; 2003 Sep; 18(17):1. PubMed ID: 14626953
    [No Abstract]   [Full Text] [Related]  

  • 17. Generic drugs. U.S. makes concession on WTO drug agreement.
    AIDS Policy Law; 2003 Jul; 18(13):1. PubMed ID: 12913964
    [No Abstract]   [Full Text] [Related]  

  • 18. Access to AIDS medicines stumbles on trade rules.
    Wise J
    Bull World Health Organ; 2006 May; 84(5):342-4. PubMed ID: 16710536
    [No Abstract]   [Full Text] [Related]  

  • 19. Essential drugs in the new international economic environment.
    Velásquez G; Boulet P
    Bull World Health Organ; 1999; 77(3):288-92. PubMed ID: 10212525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India.
    Jain D; Darrow JJ
    Health Matrix Clevel; 2013; 23(2):425-57. PubMed ID: 24341078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.